Venous Thromboses

The GORE® VIABAHN® FORTEGRA Venous Stent Post-Approval Study

The GORE® VIABAHN® FORTEGRA Venous Stent IVC Study

The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study

Leiden Thrombosis Recurrence Risk Prevention

inDividual, Targeted thrombosIS Prophylaxis Versus the Standard 'One Size Fits All' Approach in Patients Undergoing Total hIp or Total kNee replaCemenT

The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort Study

Exercise Tolerance After Venous Recanalization for Post-thrombotic Syndrome

Clonal Hematopoiesis and NETs Formation in Venous Thrombosis (CLODETTE)

Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19

TRanEXamic Acid to Decrease Heavy Menstrual Bleeding in Individuals Anticoagulated for Venous Thromboembolism Pilot Study

Aspirin® Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis in Patients With PTS

OsciPulse D-dimer Efficacy Trial

Evaluation of the OsciPulse Rapid Cycling Compression Device Effects on Venous Blood Flow

Fearon Algorithm in Warfarin Patient Self-Management

The Correlation of a D-dimer Testing Protocol With Venous Thromboembolism in Surgical Colorectal Patients

BRAVO - Betrixaban Registry Using Real Time Observations in Acute Medical Illness to Assess Venous Thrombosis and Bleeding Outcomes

Risk Factors and Prediction Model of Cancer-associated Venous Thromboembolism

Evaluation of Thromboprophylaxis Appropriateness in Hospitalized Medical Patients

Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic Events

Clotting Parameters After Medical Abortion